155 related articles for article (PubMed ID: 21207424)
1. Molecular markers of endometrial carcinoma detected in uterine aspirates.
Colas E; Perez C; Cabrera S; Pedrola N; Monge M; Castellvi J; Eyzaguirre F; Gregorio J; Ruiz A; Llaurado M; Rigau M; Garcia M; Ertekin T; Montes M; Lopez-Lopez R; Carreras R; Xercavins J; Ortega A; Maes T; Rosell E; Doll A; Abal M; Reventos J; Gil-Moreno A
Int J Cancer; 2011 Nov; 129(10):2435-44. PubMed ID: 21207424
[TBL] [Abstract][Full Text] [Related]
2. Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.
Martinez-Garcia E; Lesur A; Devis L; Campos A; Cabrera S; van Oostrum J; Matias-Guiu X; Gil-Moreno A; Reventos J; Colas E; Domon B
Oncotarget; 2016 Aug; 7(33):53102-53115. PubMed ID: 27447978
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis of endometrial cancer from uterine aspirates.
Perez-Sanchez C; Colas E; Cabrera S; Falcon O; Sanchez-del-Río A; García E; Fernández-de-Castillo L; Muruzabal JC; Alvarez E; Fiol G; González C; Torrejón R; Moral E; Campos M; Repollés M; Carreras R; Jiménez-López J; Xercavins J; Aibar E; Perdones-Montero A; Lalanne E; Palicio M; Maes T; Rosell-Vives E; Nieto C; Ortega A; Pedrola N; Llauradó M; Rigau M; Doll A; Abal M; Ponce J; Gil-Moreno A; Reventós J
Int J Cancer; 2013 Nov; 133(10):2383-91. PubMed ID: 23649867
[TBL] [Abstract][Full Text] [Related]
4. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
[TBL] [Abstract][Full Text] [Related]
5. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
[No Abstract] [Full Text] [Related]
6. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME
Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060
[TBL] [Abstract][Full Text] [Related]
7. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
[TBL] [Abstract][Full Text] [Related]
11. Discovery of biomarkers of endometrial receptivity through a minimally invasive approach: a validation study with implications for assisted reproduction.
Chan C; Virtanen C; Winegarden NA; Colgan TJ; Brown TJ; Greenblatt EM
Fertil Steril; 2013 Sep; 100(3):810-7. PubMed ID: 23725802
[TBL] [Abstract][Full Text] [Related]
12. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
13. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
[TBL] [Abstract][Full Text] [Related]
14. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of PKM2 and HSPA5 as potential biomarkers for predicting high-risk endometrial carcinoma.
Teng Y; Ai Z; Wang Y; Wang J; Luo L
J Obstet Gynaecol Res; 2013 Jan; 39(1):317-25. PubMed ID: 22889453
[TBL] [Abstract][Full Text] [Related]
16. Biological markers with potential clinical value in endometrial cancer - review of the literature.
Taoussi N; Alghamdi A; Futyma K; Rechberger T
Ginekol Pol; 2017; 88(6):331-336. PubMed ID: 28727134
[TBL] [Abstract][Full Text] [Related]
17. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
[TBL] [Abstract][Full Text] [Related]
18. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
19. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
Onuma K; Dabbs DJ; Bhargava R
Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
[TBL] [Abstract][Full Text] [Related]
20. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.
Wong YF; Cheung TH; Lo KW; Yim SF; Siu NS; Chan SC; Ho TW; Wong KW; Yu MY; Wang VW; Li C; Gardner GJ; Bonome T; Johnson WB; Smith DI; Chung TK; Birrer MJ
Oncogene; 2007 Mar; 26(13):1971-82. PubMed ID: 17043662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
